<SEC-DOCUMENT>0001474506-25-000065.txt : 20250328
<SEC-HEADER>0001474506-25-000065.hdr.sgml : 20250328
<ACCEPTANCE-DATETIME>20250328203122
ACCESSION NUMBER:		0001474506-25-000065
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20240730
FILED AS OF DATE:		20250328
DATE AS OF CHANGE:		20250328

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			John A. Ballantyne Revocable Living Trust dated 08/01/2017
		CENTRAL INDEX KEY:			0002046615
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41141
		FILM NUMBER:		25788403

	BUSINESS ADDRESS:	
		STREET 1:		301 ROUTE 17 NORTH, SUITE 800
		CITY:			RUTHERFORD
		STATE:			NJ
		ZIP:			07070
		BUSINESS PHONE:		2018427715

	MAIL ADDRESS:	
		STREET 1:		301 ROUTE 17 NORTH, SUITE 800
		CITY:			RUTHERFORD
		STATE:			NJ
		ZIP:			07070

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Glucotrack, Inc.
		CENTRAL INDEX KEY:			0001506983
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				980668934
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		301 RT 17 NORTH
		STREET 2:		SUITE 800
		CITY:			RUTHERFORD
		STATE:			NJ
		ZIP:			07070
		BUSINESS PHONE:		972 (8) 675-7878

	MAIL ADDRESS:	
		STREET 1:		301 RT 17 NORTH
		STREET 2:		SUITE 800
		CITY:			RUTHERFORD
		STATE:			NJ
		ZIP:			07070

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GlucoTrack, Inc.
		DATE OF NAME CHANGE:	20220328

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Integrity Applications, Inc.
		DATE OF NAME CHANGE:	20101203
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2024-07-30</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001506983</issuerCik>
        <issuerName>Glucotrack, Inc.</issuerName>
        <issuerTradingSymbol>GCTK</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0002046615</rptOwnerCik>
            <rptOwnerName>John A. Ballantyne Revocable Living Trust dated 08/01/2017</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>7410 CLAIRE DRIVE SOUTH</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>FARGO</rptOwnerCity>
            <rptOwnerState>ND</rptOwnerState>
            <rptOwnerZipCode>58104</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock, par value $0.001 per share</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>51002</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">John A. Ballantyne is the trustee of the reporting person and has sole voting and investment power over all securities owned by the reporting person.</footnote>
    </footnotes>

    <remarks>Exhibit List:
Exhibit 24 - Power of Attorney

Note: On May 17, 2024, a 1-for-5 reverse stock split of the Issuer's common stock, par value $0.001 per share (the &quot;Common Stock&quot;) was implemented (the &quot;2024 Reverse Split&quot;). On February 25, 2025, a 1-for-20 reverse stock split of the Common Stock was implemented (the &quot;2025 Reverse Split,&quot; and together with the 2024 Reverse Split, the &quot;Reverse Stock Splits&quot;). All figures presented in this Form 3 reflect the Reverse Stock Splits.</remarks>

    <ownerSignature>
        <signatureName>/s/ Nelson Mullins Riley &amp; Scarborough LLP, Attorney-in-Fact</signatureName>
        <signatureDate>2025-03-28</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>poa_ballantynetrust.txt
<DESCRIPTION>POWER OF ATTORNEY
<TEXT>
POWER OF ATTORNEY

Known all by these present, that the undersigned hereby constitutes and
appoints each of David Mannheim, Esq., Kathryn Simons, Esq., Joy Zheng, Esq.,
or any other representatives of Nelson Mullins Riley & Scarborough LLP, and
each of them acting along, signing single, the undersigned's true and lawful
attorney-in-fact to:

(1) execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer, director, or 10% or more stockholder, as applicable,
of Glucotrack, Inc. (the "Company"), Forms ID Application in order to obtain
EDGAR filing codes, 3, 4, 5, Update Passphrase Acknowledgement
(and any amendments thereto) in accordance with Section 16(a) of the
Securities Exchange Act of 1934, as amended (the "1934 Act") and
Schedule 13D and/or Schedule 13G (and any amendment thereto) in accordance
with the 1934 Act, and the rules promulgated thereunder;

(2) do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such
Application on Form ID, 3, 4, 5, Update Passphrase Acknowledgment and
Schedule 13D and/or Schedule 13G (and any amendments thereto) and to file
timely such form with the United States Securities and Exchange Commission
and any stock exchange or similar authority; and

(3) take any other action of any type whatsoever in connection with the
foregoing which in the opinion of such attorney-in-fact may be of benefit
to, in the best interest of, or legally required by, the undersigned, it
being understood that the documents executed by such attorney-in-fact on
behalf of the undersigned pursuant to this Power of Attorney shall be in
such form and shall contain such terms and conditions as such
attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of
the rights and powers herein granted, as fully to all intents and purposes
as the undersigned might or could do if personally present, with full power
of substitution or revocation, hereby ratifying and confirming all that
such attorney-in-fact, or such attorney-in-fact's substitute or substitutes,
shall lawfully do or cause to be done by virtue of this power of attorney
and the rights and powers herein granted. The undersigned acknowledges that
the foregoing attorneys-in-fact, in serving in such capacity at the request
of the undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the 1934 Act.

This Power of Attorney will remain in full force and effect until the
undersigned is no longer required to file Forms ID, 3, 4, 5 and
Schedule 13D and Schedule 13G with respect to the undersigned's holdings of
and transactions in securities issued by the Company, unless earlier revoked
by the undersigned in a signed writing delivered to each of the foregoing
attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 22nd day of November, 2024.

John A Ballantyne Rev Trust 08/01/2017

_/s/ John Ballantyne__________________________
By: John Ballantyne
Title: Trustee
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
